KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Bio-Rad Laboratories' Non-Current Deferred Tax Liability rose 2687.66% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 2687.66%. This contributed to the annual value of $1.2 billion for FY2025, which is 2687.66% up from last year.
  • Per Bio-Rad Laboratories' latest filing, its Non-Current Deferred Tax Liability stood at $1.2 billion for Q4 2025, which was up 2687.66% from $872.6 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Non-Current Deferred Tax Liability registered a high of $3.6 billion during Q3 2021, and its lowest value of $840.8 million during Q1 2025.
  • For the 5-year period, Bio-Rad Laboratories' Non-Current Deferred Tax Liability averaged around $1.7 billion, with its median value being $1.5 billion (2022).
  • Per our database at Business Quant, Bio-Rad Laboratories' Non-Current Deferred Tax Liability soared by 9861.24% in 2021 and then plummeted by 5840.66% in 2022.
  • Over the past 5 years, Bio-Rad Laboratories' Non-Current Deferred Tax Liability (Quarter) stood at $3.2 billion in 2021, then plummeted by 40.73% to $1.9 billion in 2022, then fell by 14.43% to $1.6 billion in 2023, then tumbled by 43.59% to $927.2 million in 2024, then increased by 26.88% to $1.2 billion in 2025.
  • Its Non-Current Deferred Tax Liability stands at $1.2 billion for Q4 2025, versus $872.6 million for Q3 2025 and $961.0 million for Q2 2025.